Planned trial of ganetespib + radiotherapy in prostate cancer.
Status: Not yet recruiting
Phase of Trial: Clinical Phase Unknown
Latest Information Update: 06 Aug 2013
Price : $35 *
At a glance
- Drugs Ganetespib (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 06 Aug 2013 This trial is expected to be initiated in late 2013 or early 2014, according to a Synta Pharmaceuticals media release.
- 06 Aug 2013 New trial record